Literature DB >> 26146597

Pragmatic and Ethical Challenges of Incorporating the Genome into the Electronic Medical Record.

Adam A Nishimura1, Peter Tarczy-Hornoch2, Brian H Shirts3.   

Abstract

Recent successes in the use of gene sequencing for patient care highlight the potential of genomic medicine. For genomics to become a part of usual care, pertinent elements of a patient's genomic test must be communicated to the most appropriate care providers. Electronic medical records may serve as a useful tool for storing and disseminating genomic data. Yet, the structure of existing EMRs and the nature of genomic data pose a number of pragmatic and ethical challenges in their integration. Through a review of the recent genome-EMR integration literature, we explore concrete examples of these challenges, categorized under four key questions: What data will we store? How will we store it? How will we use it? How will we protect it? We conclude that genome-EMR integration requires a rigorous, multi-faceted and interdisciplinary approach of study. Problems facing the field are numerous, but few are intractable.

Entities:  

Keywords:  Computerized Prescriber Order Entry; Genomic medicine; clinical decision support; clinical genomics; clinical informatics; electronic medical records; genotype; implementation science; individualized medicine; personalized medicine; pharmacogenetics; pharmacogenomics; translational research

Year:  2014        PMID: 26146597      PMCID: PMC4489153          DOI: 10.1007/s40142-014-0051-9

Source DB:  PubMed          Journal:  Curr Genet Med Rep        ISSN: 2167-4876


  68 in total

1.  The coming explosion in genetic testing--is there a duty to recontact?

Authors:  Reed E Pyeritz
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

2.  The extent and importance of unintended consequences related to computerized provider order entry.

Authors:  Joan S Ash; Dean F Sittig; Eric G Poon; Kenneth Guappone; Emily Campbell; Richard H Dykstra
Journal:  J Am Med Inform Assoc       Date:  2007-04-25       Impact factor: 4.497

Review 3.  Antiplatelet therapy: new pharmacological agents and changing paradigms.

Authors:  D Capodanno; J L Ferreiro; D J Angiolillo
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

4.  Informed consent for population-based research involving genetics.

Authors:  L M Beskow; W Burke; J F Merz; P A Barr; S Terry; V B Penchaszadeh; L O Gostin; M Gwinn; M J Khoury
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

5.  PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.

Authors:  James M Hoffman; Cyrine E Haidar; Mark R Wilkinson; Kristine R Crews; Donald K Baker; Nancy M Kornegay; Wenjian Yang; Ching-Hon Pui; Ulrike M Reiss; Aditya H Gaur; Scott C Howard; William E Evans; Ulrich Broeckel; Mary V Relling
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-03-11       Impact factor: 3.908

6.  A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Authors:  Stephen E Kimmel; Benjamin French; Scott E Kasner; Julie A Johnson; Jeffrey L Anderson; Brian F Gage; Yves D Rosenberg; Charles S Eby; Rosemary A Madigan; Robert B McBane; Sherif Z Abdel-Rahman; Scott M Stevens; Steven Yale; Emile R Mohler; Margaret C Fang; Vinay Shah; Richard B Horenstein; Nita A Limdi; James A S Muldowney; Jaspal Gujral; Patrice Delafontaine; Robert J Desnick; Thomas L Ortel; Henny H Billett; Robert C Pendleton; Nancy L Geller; Jonathan L Halperin; Samuel Z Goldhaber; Michael D Caldwell; Robert M Califf; Jonas H Ellenberg
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

7.  The rules remain the same for genomic medicine: the case against "reverse genetic exceptionalism".

Authors:  James P Evans; Wylie Burke; Muin Khoury
Journal:  Genet Med       Date:  2010-06       Impact factor: 8.822

8.  Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support.

Authors:  Casey Lynnette Overby; Peter Tarczy-Hornoch; James I Hoath; Ira J Kalet; David L Veenstra
Journal:  BMC Bioinformatics       Date:  2010-10-28       Impact factor: 3.169

Review 9.  Next-generation sequencing and epigenomics research: a hammer in search of nails.

Authors:  Shrutii Sarda; Sridhar Hannenhalli
Journal:  Genomics Inform       Date:  2014-03-31

Review 10.  The curation of genetic variants: difficulties and possible solutions.

Authors:  Kapil Raj Pandey; Narendra Maden; Barsha Poudel; Sailendra Pradhananga; Amit Kumar Sharma
Journal:  Genomics Proteomics Bioinformatics       Date:  2012-11-29       Impact factor: 7.691

View more
  4 in total

1.  Security controls in an integrated Biobank to protect privacy in data sharing: rationale and study design.

Authors:  Takako Takai-Igarashi; Kengo Kinoshita; Masao Nagasaki; Soichi Ogishima; Naoki Nakamura; Sachiko Nagase; Satoshi Nagaie; Tomo Saito; Fuji Nagami; Naoko Minegishi; Yoichi Suzuki; Kichiya Suzuki; Hiroaki Hashizume; Shinichi Kuriyama; Atsushi Hozawa; Nobuo Yaegashi; Shigeo Kure; Gen Tamiya; Yoshio Kawaguchi; Hiroshi Tanaka; Masayuki Yamamoto
Journal:  BMC Med Inform Decis Mak       Date:  2017-07-06       Impact factor: 2.796

2.  The anatomy of electronic patient record ethics: a framework to guide design, development, implementation, and use.

Authors:  Tim Jacquemard; Colin P Doherty; Mary B Fitzsimons
Journal:  BMC Med Ethics       Date:  2021-02-04       Impact factor: 2.652

3.  Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes.

Authors:  Samantha N Piekos; Sadhana Gaddam; Pranav Bhardwaj; Prashanth Radhakrishnan; Ramanathan V Guha; Anthony E Oro
Journal:  PLoS Comput Biol       Date:  2021-09-20       Impact factor: 4.475

4.  Examination and diagnosis of electronic patient records and their associated ethics: a scoping literature review.

Authors:  Tim Jacquemard; Colin P Doherty; Mary B Fitzsimons
Journal:  BMC Med Ethics       Date:  2020-08-24       Impact factor: 2.652

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.